Zoetis, Inc. (ZTS)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Zoetis, Inc. (ZTS)

Go deeper and ask any question about ZTS

Company Performance

Current Price

as of Oct 04, 2024

$190.03

P/E Ratio

37.21

Market Cap

$86.09B

Description

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Metrics

Overview

  • HQParsippany, NJ
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerZTS
  • Price$190.03-0.50%

Trading Information

  • Market Cap$86.09B
  • Float99.91%
  • Average Daily Volume (1m)1,845,192
  • Average Daily Volume (3m)1,864,230
  • EPS$5.12

Company

  • Revenue$8.92B
  • Rev Growth (1yr)8.30%
  • Net Income$624.00M
  • Gross Margin70.22%
  • EBITDA Margin43.75%
  • EBITDA$1.03B
  • EV$84.22B
  • EV/Revenue9.45
  • P/E37.21
  • P/S9.72